Related Experiment Video
Updated: Aug 8, 2026

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Bleeding Disorders Research Collaborative: an opportunity for impact
Maria E Santaella1, Sammie Valadez2, Esmeralda Vázquez3
1National Bleeding Disorders Foundation, New York, NY, USA.
Expert Review of Hematology
|August 7, 2026
Summary
The National Bleeding Disorders Foundation (NBDF) established a Bleeding Disorders Research Collaborative (BDRC) to address unmet needs. This collaborative prioritizes community input, lived experience, and health equity to advance research for inheritable bleeding disorders.
Area of Science:
- Medical Research
- Public Health Initiatives
- Community Engagement
Background:
- The National Research Blueprint outlines a new Bleeding Disorders Research Collaborative (BDRC).
- This initiative is driven by community-identified unmet needs in inheritable bleeding disorders.
- The National Bleeding Disorders Foundation (NBDF) led a five-year co-creation process involving diverse stakeholders.
Purpose of the Study:
- To propose a novel research collaborative structure for inheritable bleeding disorders.
- To integrate principles of people, priorities, and community-driven needs.
- To foster health equity, diversity, and inclusion within research.
Main Methods:
- Seven multidisciplinary working groups convened to develop the blueprint.
- The blueprint incorporates research and development, workforce, infrastructure, community engagement, policy, lived experience expertise, and health equity.
- Emphasis on education, training, and mentorship for diverse research teams.
Main Results:
- A comprehensive blueprint for the Bleeding Disorders Research Collaborative (BDRC) has been drafted.
- The proposed collaborative aims to engage the entire inheritable bleeding disorders community.
- Focus on empowering diverse research teams through respectful partnerships.
Conclusions:
- The BDRC has the potential to transform inheritable bleeding disorders research.
- Its collaborative infrastructure centers lived experience and health equity.
- The initiative aims to efficiently advance health justice for the bleeding disorders community.
Related Concept Videos
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Blood Transfusion
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
